An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome

Key facts

Sponsor

The Cleveland Clinic

Principal Investigator

Daniel Sessler, MD, MD

The Cleveland Clinic

Intervention

Intravenous infusion(procedure)

Enrollment

4 enrolled

Eligibility

5-25 years · FEMALE

Timeline

2015 – 2017

Study locations (1)

• Cleveland Clinic, Cleveland, Ohio, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Rett syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT06840496
  To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
  Biomed Industries, Inc.
• RECRUITINGPHASE2NCT07430046
  Repurposing Mirtazapine in Rett Syndrome
  University of Trieste
• RECRUITINGNCT06338267
  Validating Innovative Biosensors for Rett Autonomic Symptom Tracking
  Rett Syndrome Research Trust
• RECRUITINGEARLY PHASE1NCT06856759
  Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome
  Guangzhou Women and Children's Medical Center
• RECRUITINGNCT06705816
  Cognitive Function in Rett Syndrome During Trofinetide Treatment
  University of Minnesota
• ENROLLING BY INVITATIONNANCT06739434
  GCB-002 in Treatment of Patients With Rett Syndrome
  Genecombio Ltd.
• ACTIVE NOT RECRUITINGNANCT07418905
  Technology-supported Motor Rehabilitation for People With Rett Syndrome
  Georgetown University
• ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06152237
  Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)
  Taysha Gene Therapies, Inc.

See all trials for Rett syndrome →